Patents by Inventor Cristiane Secca da Silva

Cristiane Secca da Silva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-IL12RB1 antibodies
    Patent number: 11952417
    Abstract: The present invention is directed towards isolated antibodies that bind to IL12R?1. Specifically, anti-IL12R?1 antibodies, and methods of treatment using the antibodies are disclosed. The antibody is targeted against the beta 1 subunit of the receptors of IL-12 and IL-23 and is capable of blocking signaling by inflammatory cytokines IL-12 and IL-23, which could be useful in treating autoimmune inflammatory diseases, such as inflammatory bowel disease (IBD), RA, and psoriasis.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: April 9, 2024
    Assignee: Washington University
    Inventors: Marco Colonna, Cristiane Secca da Silva
  • ANTI-IL12RB1 ANTIBODIES
    Publication number: 20220177567
    Abstract: The present invention is directed towards isolated antibodies that bind to IL12R?1. Specifically, anti-IL12R?1 antibodies, and methods of treatment using the antibodies are disclosed. The antibody is targeted against the beta 1 subunit of the receptors of IL-12 and IL-23 and is capable of blocking signaling by inflammatory cytokines IL-12 and IL-23, which could be useful in treating autoimmune inflammatory diseases, such as inflammatory bowel disease (IBD), RA, and psoriasis.
    Type: Application
    Filed: December 9, 2021
    Publication date: June 9, 2022
    Inventors: Marco Colonna, Cristiane Secca da Silva